International Innovative Oncology Companies Roadshow Showcase

2019 China BioMed Innovation and Investment Conference

(adjacent to Novotel Suzhou SIP hotel)

> 500 investment firms
> 500 biomedical companies
> 4,500 screened Conference attendees, including Chinese and other government, industry, scientific and hospital decision makers

Full-day parallel session
Keynote speaker(s)
Investment pitches by senior executives of select U.S. or other non-Chinese oncology technology companies

For the third year in a row, the National Foundation for Cancer Research (NFCR) has been chosen by the hosts of Asia's most significant annual biomedical industry investment gathering, the China BioMed Innovation and Investment Conference (CBIIC), to recruit and organize the event's only featured component dedicated to oncology companies seeking access to Chinese investors and other partners. Additional foreign, non-Chinese firms too are being included.
Select U.S. or other non-Chinese oncology technology companies will be highlighted in a parallel session within CBIIC, featuring 20 to 30 minute pitches by their senior executives to an audience forecast at least between 200 to 300 persons, including 75 to 100 screened investors. Total conference is forecast to have over 4,000 attendees.
Participation as a presenting oncology technology company will also avail access to the rest of CBIIC's three day programming, as well as an array of services being offered by NFCR and its partner, the China Pharmaceutical Innovation and Research Development Association (PhIRDA)--one of the Conference's three hosts.
Sponsorship opportunities for the 2019 CBIIC International Showcase parallel session are also available.